HOXB7 and esophageal squamous cell carcinoma: Multivariate survival analysis confirmed that the HOXB7 expression and TNM stage were two independent prognostic factors for overall survival in patients with ESCC (Table 3, HR [95% CI] = 0.573[0.341–0.963], p = 0.036 for HOXB7 low expression).